Drug class
Antiandrogen
An antiandrogen is a member of a pharmacologic class of agents that counteracts or inhibits the biological effects of male sex hormones, primarily testosterone and dihydrotestosterone. Read more about Antiandrogen
16 drugs in this class 15 manufacturers
Drugs in Antiandrogen
BICALUTAMIDE
BICALUTAMIDE
BICALUTAMIDE
BICALUTAMIDE
XTANDI (enzalutamide)
NILUTAMIDE
NILANDRON (nilutamide)
BICALUTAMIDE
An antiandrogen is a member of a pharmacologic class of agents that counteracts or inhibits the biological effects of male sex hormones, primarily testosterone and dihydrotestosterone.
These drugs function chiefly as competitive antagonists by binding to cytosolic and nuclear androgen receptors in target tissues, thereby suppressing receptor activation and downstream gene expression required for cellular growth and function.
Antiandrogens are primarily indicated in oncology for the treatment of hormone-dependent prostate cancer, frequently as part of combined androgen deprivation regimens.
Additionally, antiandrogenic agents are widely utilized in dermatology and endocrinology to manage conditions driven by androgen excess or hypersensitivity, including acne vulgaris, hirsutism, androgenetic alopecia, and precocious puberty.
-
fda.gov
An antiandrogen is a member of a pharmacologic class of agents that counteracts or inhibits the biological effects of male sex hormones, primarily testosterone and dihydrotestosterone These drugs function chiefly as competitive antagonists by binding to cytosolic and nuclear androgen receptors in target tissues, thereby suppressing receptor activation and downstream gene expression required for cellular growth and function Antiandrogens are primarily indicated in oncology for the treatment of ho...
-
cancer.gov
An antiandrogen is a member of a pharmacologic class of agents that counteracts or inhibits the biological effects of male sex hormones, primarily testosterone and dihydrotestosterone These drugs function chiefly as competitive antagonists by binding to cytosolic and nuclear androgen receptors in target tissues, thereby suppressing receptor activation and downstream gene expression required for cellular growth and function Antiandrogens are primarily indicated in oncology for the treatment of ho...
-
cancer.gov
These drugs function chiefly as competitive antagonists by binding to cytosolic and nuclear androgen receptors in target tissues, thereby suppressing receptor activation and downstream gene expression required for cellular growth and function
-
fda.gov
Additionally, antiandrogenic agents are widely utilized in dermatology and endocrinology to manage conditions driven by androgen excess or hypersensitivity, including acne vulgaris, hirsutism, androgenetic alopecia, and precocious puberty
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.